These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 1014711

  • 1. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F, Mauser R.
    Wien Klin Wochenschr; 1976 Dec 10; 88(23):777-81. PubMed ID: 1014711
    [Abstract] [Full Text] [Related]

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 10; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 3. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 4. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.
    Rev Med Chil; 2000 Sep 17; 128(9):955-61. PubMed ID: 11349499
    [Abstract] [Full Text] [Related]

  • 5. Renin-angiotensin-aldosterone system in arterial hypertension.
    Horký K, Gregorová I.
    Cor Vasa; 1980 Sep 17; 22(1-2):59-73. PubMed ID: 6995018
    [Abstract] [Full Text] [Related]

  • 6. Primary aldosteronism, a common entity? the myth persists.
    Padfield PL.
    J Hum Hypertens; 2002 Mar 17; 16(3):159-62. PubMed ID: 11896504
    [Abstract] [Full Text] [Related]

  • 7. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L, Fardella C, Montero J, Rojas P, Sánchez O, Rojas V, Rojas A, Huete A, Soto J, Foradori A.
    Rev Med Chil; 1999 Jul 17; 127(7):800-6. PubMed ID: 10668287
    [Abstract] [Full Text] [Related]

  • 8. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep 17; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL, Opie LH, Davidson JS.
    S Afr Med J; 2000 Apr 17; 90(4):394-400. PubMed ID: 10957926
    [Abstract] [Full Text] [Related]

  • 14. Essential arterial hypertension: plasma and urinary aldosterone alterations.
    Garcia Zozaya JL, Padilla Viloria M, Castro A.
    South Med J; 1987 Oct 17; 80(10):1224-7. PubMed ID: 3310248
    [Abstract] [Full Text] [Related]

  • 15. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH, Man in 't Veld AJ, Verhoeven RP, Derkx FH, Schalekamp DH.
    Circ Res; 1977 May 17; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [Abstract] [Full Text] [Related]

  • 16. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC, Machado FS, da Silva EP, Lutucuta S, Almeida G, Coucelo J, Vagueiro C.
    Rev Port Cardiol; 1999 Sep 17; 18(9):801-12. PubMed ID: 10536470
    [Abstract] [Full Text] [Related]

  • 17. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J.
    Exp Clin Endocrinol Diabetes; 2002 Apr 17; 110(2):80-5. PubMed ID: 11928071
    [Abstract] [Full Text] [Related]

  • 18. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.
    Hypertens Res; 2010 Aug 17; 33(8):850-6. PubMed ID: 20520614
    [Abstract] [Full Text] [Related]

  • 19. [Monogenic hypertension].
    Bähr V, Oelkers W, Diederich S.
    Med Klin (Munich); 2003 Apr 15; 98(4):208-17. PubMed ID: 12715144
    [Abstract] [Full Text] [Related]

  • 20. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
    Maule S, Mulatero P, Milan A, Leotta G, Caserta M, Bertello C, Rabbia F, Veglio F.
    J Hypertens; 2006 Dec 15; 24(12):2459-64. PubMed ID: 17082730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.